Drugging the Other KRAS Mutants

Time: 10:00 am
day: Day One


• Boehringer Ingelheim is taking a systematic approach to discovering drugs for all KRAS mutants

• The potential approaches to drugging KRAS beyond G12C with small molecules will be discussed

• Highlights from some of Boehringer Ingelheim’s KRAS programs will be presented